Deutsche Bank
IMVT icon

Deutsche Bank’s Immunovant IMVT Stock Holding History

Deutsche Bank’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.64M Buy
137,459
+38,864
+39% +$1.53M ﹤0.01% 1288
2026
Q2 		$3.8M Buy
98,595
+19,595
+25% +$597K ﹤0.01% 1520
2026
Q1 		$1.96M Buy
79,000
+16,542
+26% +$428K ﹤0.01% 1786
2025
Q4 		$1.59M Buy
62,458
+7,673
+14% +$171K ﹤0.01% 1928
2025
Q3 		$883K Buy
54,785
+6,014
+12% +$97.4K ﹤0.01% 2246
2025
Q2 		$780K Sell
48,771
-362,738
-88% -$5.49M ﹤0.01% 2234
2025
Q1 		$7.03M Buy
411,509
+245,037
+147% +$5.13M ﹤0.01% 1122
2024
Q4 		$4.12M Buy
166,472
+16,903
+11% +$479K ﹤0.01% 1429
2024
Q3 		$4.26M Buy
149,569
+6,595
+5% +$195K ﹤0.01% 1345
2024
Q2 		$3.77M Sell
142,974
-2,451
-2% -$69.7K ﹤0.01% 1346
2024
Q1 		$4.7M Buy
145,425
+1,032
+0.7% +$37.6K ﹤0.01% 1291
2023
Q4 		$6.08M Buy
144,393
+109,400
+313% +$4.03M ﹤0.01% 1169
2023
Q3 		$1.34M Sell
34,993
-107,689
-75% -$2.43M ﹤0.01% 1560
2023
Q2 		$2.71M Buy
142,682
+102,461
+255% +$1.91M ﹤0.01% 1484
2023
Q1 		$624K Buy
40,221
+8,253
+26% +$143K ﹤0.01% 2369
2022
Q4 		$567K Buy
31,968
+5,381
+20% +$67.8K ﹤0.01% 2377
2022
Q3 		$148K Buy
26,587
+7,257
+38% +$35.5K ﹤0.01% 3127
2022
Q2 		$75K Sell
19,330
-4,278
-18% -$18.5K ﹤0.01% 3634
2022
Q1 		$130K Sell
23,608
-123,029
-84% -$766K ﹤0.01% 3478
2021
Q4 		$1.25M Buy
146,637
+1,548
+1% +$12.8K ﹤0.01% 2301
2021
Q3 		$1.26M Sell
145,089
-39,368
-21% -$355K ﹤0.01% 2464
2021
Q2 		$1.95M Buy
184,457
+24,511
+15% +$342K ﹤0.01% 2250
2021
Q1 		$2.57M Buy
159,946
+128,765
+413% +$3.4M ﹤0.01% 1983
2020
Q4 		$1.44M Buy
31,181
+10,105
+48% +$467K ﹤0.01% 2175
2020
Q3 		$742K Sell
21,076
-97,021
-82% -$2.92M ﹤0.01% 2386
2020
Q2 		$2.88M Buy
+118,097
New +$2.53M ﹤0.01% 1584

Other funds holding IMVT

Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Deutsche Bank's IMVT Position: Q3 2026 in Review

Deutsche Bank increased its Immunovant (IMVT) stake by 39% in Q3 2026, buying an estimated $1.53M and bringing the position to 137,459 shares worth $4.64M. The position accounts for ﹤0.01% of the portfolio, ranked #1288.

Deutsche Bank first reported a position in IMVT in Q2 2020 and has held it in 26 quarters since. The position peaked at $7.03M in Q1 2025. 72 funds tracked by Wall St. Rank hold IMVT as of Q3 2026.

  • Deutsche Bank held 137,459 shares of Immunovant worth $4.64M as of Q3 2026.
  • Deutsche Bank bought 38,864 Immunovant shares in Q3 2026, an estimated $1.53M.
  • Immunovant made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #1288 holding.
  • Deutsche Bank first reported a position in Immunovant in Q2 2020 and has held it in 26 quarters since.
  • Deutsche Bank's Immunovant position peaked at $7.03M in Q1 2025.
  • 72 funds tracked by Wall St. Rank held Immunovant as of Q3 2026.

Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.